These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 2146652)

  • 1. [Familial pheochromocytoma and Van Hippel-Lindau disease].
    Gautier JF; Schlumberger M; Fonseca E; Adotti F; Bosq J; Comoy E; Billebaud T; Parmentier C
    Presse Med; 1990 Oct; 19(32):1494-6. PubMed ID: 2146652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cell carcinoma in a von Hippel-Lindau syndrome: when should phaeochromocytoma be anticipated?
    Azarisman SM; Nor Azmi K
    Singapore Med J; 2007 Aug; 48(8):779-82. PubMed ID: 17657389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.
    Neumann HP; Berger DP; Sigmund G; Blum U; Schmidt D; Parmer RJ; Volk B; Kirste G
    N Engl J Med; 1993 Nov; 329(21):1531-8. PubMed ID: 8105382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumors outside of the central nervous system in Von Hippel-Lindau disease].
    Veltman GA; Arntzenius AB; Oosterwijk JC; Lycklamaá Nijeholt AA; Roelfsema F
    Ned Tijdschr Geneeskd; 1996 Apr; 140(15):823-6. PubMed ID: 8668275
    [No Abstract]   [Full Text] [Related]  

  • 5. Familial phaeochromocytoma with von Hippel's disease in one sister and ectopic adrenal cortex in the kidney in another.
    Mendelow AD; Kay S; Levin E; Mieny CJ
    Br J Surg; 1978 Feb; 65(2):138-40. PubMed ID: 626828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pheochromocytoma in Von Hippel Lindau disease. 3 cases].
    Tourniaire J; Pradat P; Chalendar D
    Ann Endocrinol (Paris); 1995; 56(6):609-12. PubMed ID: 8787353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular diagnosis of von Hippel-Lindau disease in a kindred with a predominance of familial phaeochromocytoma.
    Garcia A; Matias-Guiu X; Cabezas R; Chico A; Prat J; Baiget M; De Leiva A
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):359-63. PubMed ID: 9156047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors.
    Jimenez C; Cabanillas ME; Santarpia L; Jonasch E; Kyle KL; Lano EA; Matin SF; Nunez RF; Perrier ND; Phan A; Rich TA; Shah B; Williams MD; Waguespack SG
    J Clin Endocrinol Metab; 2009 Feb; 94(2):386-91. PubMed ID: 19017755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma.
    Walther MM; Reiter R; Keiser HR; Choyke PL; Venzon D; Hurley K; Gnarra JR; Reynolds JC; Glenn GM; Zbar B; Linehan WM
    J Urol; 1999 Sep; 162(3 Pt 1):659-64. PubMed ID: 10458336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pheochromocytoma and clear-cell renal carcinoma in a child with von Hippel-Lindau disease: a patient report.
    Ferragut J; Caimari M; Rituerto B; Gómez-Rivas B; Herrera M; Alonso F
    J Pediatr Endocrinol Metab; 1999; 12(4):579-82. PubMed ID: 10417977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pheochromocytoma in Von Hippel Lindau disease. Apropos of a case of per-operative presentation].
    Potier F; Brasdfer D; Castier P; Cantineau D; Constantinides G
    Bull Soc Ophtalmol Fr; 1989 Feb; 89(2):251-2. PubMed ID: 2805197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral pheochromocytoma as first manifestation of von Hippel-Lindau disease: a case report.
    Catli G; Abaci A; Neumann HC; Altincik A; Demir K; Böber E
    Turk J Pediatr; 2012; 54(5):532-5. PubMed ID: 23427520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Posterior reversible leukoencephalopathy syndrome, pheochromocytoma and von Hippel-Lindau disease].
    Rodríguez-Uranga JJ; Franco-Macías E; Bernal Sánchez-Arjona M; Villalobos-Chávez F
    Rev Neurol; 2003 Oct 16-31; 37(8):797-8. PubMed ID: 14593644
    [No Abstract]   [Full Text] [Related]  

  • 14. Von Hippel-Lindau disease and pheochromocytoma.
    Walther MM; Linehan WM
    JAMA; 1996 Mar; 275(11):839-40. PubMed ID: 8596219
    [No Abstract]   [Full Text] [Related]  

  • 15. Pheochromocytoma as the first manifestation of von Hippel-Lindau disease.
    Richard S; Beigelman C; Duclos JM; Fendler JP; Plauchu H; Plouin PF; Resche F; Schlumberger M; Vermesse B; Proye C
    Surgery; 1994 Dec; 116(6):1076-81. PubMed ID: 7985090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phaeochromocytoma associated with a de novo VHL mutation as form fruste of von Hippel-Lindau disease.
    Frenzel S; Apel TW; Heidemann PH; Zerres K; Neumann HP; Dörr HG
    Eur J Pediatr; 2001 Jul; 160(7):421-4. PubMed ID: 11475579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pheochromocytoma and multifocal functioning paraganglioma in a 9-year-old boy with von Hippel-Lindau disease.
    Tröbs RB; Reichardt P; Friedrich T; Klöppel R; Bennek J
    Urol Int; 2002; 68(4):299-301. PubMed ID: 12053037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of hereditary pheochromocytoma in von Hippel-Lindau kindreds with partial adrenalectomy.
    Walther MM; Keiser HR; Choyke PL; Rayford W; Lyne JC; Linehan WM
    J Urol; 1999 Feb; 161(2):395-8. PubMed ID: 9915410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pancreatic neuroendocrine tumors and von Hippel-Lindau disease].
    Musso C; Paraf F; Petit B; Archambeaud-Mouveroux F; Valleix D; Labrousse F
    Ann Pathol; 2000 Mar; 20(2):130-3. PubMed ID: 10740008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hereditary pheochromocytoma--a family affected by von Hippel-Lindau disease].
    Mertl J; Rovný A; Krepelová A; Prásek J
    Vnitr Lek; 2003 Jul; 49(7):572-5. PubMed ID: 12931443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.